Scholarlink

Background <p>Monitoring the genetic diversity of the drug-resistant <i>Mycobacterium tuberculosis</i> (Mtb) population contributes to gaining better insight into the bacterial dynamics and informing effective strategies to tackle the challenge of drug resistance. This meta-analysis study investigates the pooled prevalence of Mtb genotypes among Iranian multidrug-resistant (MDR)/extensively drug-resistant (XDR)-TB patients.</p> Methods <p>We performed a systematic search across repositories, including PubMed, Scopus, Web of Science, and Iranian databases, to find studies reporting Mtb genotype prevalence among Iranian MDR/XDR-TB patients through 31 August 2024. Random-effects or fixed-effect models were used to evaluate the pooled proportion. Statistical analysis was conducted using a meta package in R software.</p> Results <p>In this meta-analysis, 26 out of 34 included studies focused on MDR genotypes, while the remaining studies addressed the prevalence of pre-/XDR genotypes. The prevalence results for MDR genotypes showed that Haarlem (28.5%, 95% CI: 24.6–32.8), Beijing (25.6%, 95% CI: 22.5–28.9), and URAL (23.8%, 95% CI: 13.3–38.9) were the most predominant genotypes. Genotypes with the lowest proportion included MANU, T, and Uganda ( &lt; 8%). The highest prevalence of pre-/XDR genotypes was identified for Beijing (57.6%, 95% CI: 35.8–76.8) and Haarlem (30.2%, 95% CI: 9.8–63.3), respectively.</p> Conclusions <p>Based on our findings, Haarlem and Beijing were highlighted as the dominant circulating genotypes among Iranian MDR- and pre-/XDR-TB cases, respectively. As the relationship between these genotypes and high levels of treatment failure has been documented, local tracking dynamics of drug-resistant Mtb population structure are critical to improving our ability to manage local MDR/XDR-TB.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genotypic diversity of multi- and extensively drug-resistant Mycobacterium tuberculosis in Iran: a systematic review and meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月15日

查看全文
  • Mansour Kargarpour Kamakoli,
  • Ehsan Zare BanadKoki,
  • Mehran Nakhaeizadeh,
  • Ava Behrouzi,
  • Nasim Ebrahimifard,
  • Shima Hadifar

摘要

Background

Monitoring the genetic diversity of the drug-resistant Mycobacterium tuberculosis (Mtb) population contributes to gaining better insight into the bacterial dynamics and informing effective strategies to tackle the challenge of drug resistance. This meta-analysis study investigates the pooled prevalence of Mtb genotypes among Iranian multidrug-resistant (MDR)/extensively drug-resistant (XDR)-TB patients.

Methods

We performed a systematic search across repositories, including PubMed, Scopus, Web of Science, and Iranian databases, to find studies reporting Mtb genotype prevalence among Iranian MDR/XDR-TB patients through 31 August 2024. Random-effects or fixed-effect models were used to evaluate the pooled proportion. Statistical analysis was conducted using a meta package in R software.

Results

In this meta-analysis, 26 out of 34 included studies focused on MDR genotypes, while the remaining studies addressed the prevalence of pre-/XDR genotypes. The prevalence results for MDR genotypes showed that Haarlem (28.5%, 95% CI: 24.6–32.8), Beijing (25.6%, 95% CI: 22.5–28.9), and URAL (23.8%, 95% CI: 13.3–38.9) were the most predominant genotypes. Genotypes with the lowest proportion included MANU, T, and Uganda ( < 8%). The highest prevalence of pre-/XDR genotypes was identified for Beijing (57.6%, 95% CI: 35.8–76.8) and Haarlem (30.2%, 95% CI: 9.8–63.3), respectively.

Conclusions

Based on our findings, Haarlem and Beijing were highlighted as the dominant circulating genotypes among Iranian MDR- and pre-/XDR-TB cases, respectively. As the relationship between these genotypes and high levels of treatment failure has been documented, local tracking dynamics of drug-resistant Mtb population structure are critical to improving our ability to manage local MDR/XDR-TB.